Serum tyrosine is associated with better cognition in Lewy body dementia

Brain Res. 2021 Aug 15;1765:147481. doi: 10.1016/j.brainres.2021.147481. Epub 2021 Apr 16.

Abstract

Amino acids' neuroactivity, and roles in excitotoxity and oxidative stress are linked to dementia. We aimed to investigate whether circulating amino acid concentrations were associated with cognitive decline in patients with mild Alzheimer's disease (AD) and Lewy body dementia (LBD). Baseline serum amino acid concentrations were measured in 89 patients with AD and 65 with LBD (13 with Parkinson's disease dementia and 52 with dementia with Lewy bodies). The Mini-Mental State Examination (MMSE) was administered at baseline and annually for five years. Associations between baseline amino acid concentrations and longitudinal MMSE score were assessed using a linear-mixed effects model stratified by diagnosis with adjustment for multiple comparisons. The results of the study indicated that serum tyrosine was positively associated with MMSE performance during the five-year follow-up period in patients with LBD (q-value = 0.012), but not AD. In conclusion, higher baseline serum concentrations of tyrosine, the precursor amino acid in dopamine and norepinephrine synthesis, was associated with better cognitive performance in patients with LBD, but not AD, throughout the 5-year follow-up period.

Keywords: Alzheimer’s disease; Cognition; Lewy body dementia; Serum tyrosine.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Aged, 80 and over
  • Alzheimer Disease / metabolism
  • Alzheimer Disease / physiopathology
  • Biomarkers / blood
  • Cognition / physiology*
  • Cognitive Dysfunction / metabolism
  • Cohort Studies
  • Female
  • Humans
  • Lewy Body Disease / metabolism*
  • Lewy Body Disease / physiopathology
  • Male
  • Tyrosine / analysis*
  • Tyrosine / blood
  • Tyrosine / metabolism

Substances

  • Biomarkers
  • Tyrosine